Dosage Forms

Articles

The sterility test isolator (STISO) for testing aseptically filled drug products and for testing toxic aseptic drugs (STISOtox) from Metall+Plastic, a subsidiary of Optima, are modular and ergonomically designed.

Sterility Test Isolators for Aseptic and Toxic Drug Products are Ergonomically Designed

Pharmaceutical machine concepts for large and small factories of the future need to be readily available, flexible when it comes to processing variation, and modular in design. 

Groninger Presents Machine Range for Large and Small Factories at Achema 2018

Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.

Albumin Attachment Can Make Better Biobetters

The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.

Haselmeier, Common Sensing to Partner on Injectable Solutions

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Determining the right process conditions for a freeze-drying cycle requires an understanding of the effect of each step on the drug product.

Freeze-Drying Process Optimization

Manuel M. Garza is a principal consultant with PAREXEL Consulting, a subsidiary of PAREXEL International, manuel.garza@parexel.com.

Airflow visualization studies, or smoke studies, confirm unidirectional airflow patterns in an aseptic processing facility.

How to Plan Smoke Studies

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

INTERPHEX presents advances in pharmaceutical container filling, robotic handling, and serialization. 

New Equipment and Software Meet Needs for Fill/Finish, Serialization, and Data Traceability

New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.

Parenteral Packaging Innovations

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.

Parenterals and Injectables